Standout Papers

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck 2006 2026 2012 2019 3.6k
  1. Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck (2006)
    James A. Bonner, Paul M. Harari et al. New England Journal of Medicine
  2. Head and neck cancer (2008)
    Athanassios Argiris, Michalis V. Karamouzis et al. The Lancet
  3. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival (2009)
    James A. Bonner, Paul M. Harari et al. The Lancet Oncology
  4. Caspase 3–mediated stimulation of tumor cell repopulation during cancer radiotherapy (2011)
    Qian Huang, Fang Li et al. Nature Medicine
  5. p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma (2014)
    Christine H. Chung, Qiang Zhang et al. Journal of Clinical Oncology

Immediate Impact

15 by Nobel laureates 7 from Science/Nature 75 standout
Sub-graph 1 of 18

Citing Papers

Theranostic Fluorescent Probes
2024 Standout
PROTAC Prodrug‐Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer
2024 Standout
3 intermediate papers

Works of David Raben being referenced

Radioimmunotherapy for the treatment of head and neck cancer
2019
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
David Raben 6676 5462 5071 234 14.9k
James A. Bonner 6482 6490 4680 230 13.8k
Paul M. Harari 8412 7072 5795 300 17.7k
Ezra E.W. Cohen 8308 5492 4559 416 16.4k
Christine H. Chung 5519 3539 7082 254 15.2k
Bonnie S. Glisson 7543 4525 5768 273 14.4k
Dora L.�W. Kwong 3339 2958 3933 216 10.8k
Merrill S. Kies 7226 5225 5611 177 14.3k
J. Giralt 5208 4481 5602 116 11.4k
K. Kian Ang 4102 4403 5241 176 11.4k
Barbara Burtness 8322 4857 4765 357 15.4k

All Works

Loading papers...

Rankless by CCL
2026